AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
Episode 20. Management of Myeloma in LMICs
Blood Cancer Talks
The Future of Clinical Trials
I think with generics, the cost definitely comes down. There is no doubt about it. It's good. We are being used. And but I don't think it's an evil Machiavellian scheme. So we've had a lot of trials here,. you know, these global response or studies are usually either RCTs and we are happy to enroll patients. But if they don't get pushed to do that, then it's never going to happen. For example, we have run the Blina Tumum map getting a little sidetracked to a LL. Now ask me how many patients have actually received Blina Tummy after the approval of the drug in our
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode